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Abstract
Background The advantages of laparoscopy are widely known. Nevertheless, its legitimacy in liver surgery is often ques-
tioned because of the uncertain value associated with minimally invasive methods. Our main goal was to compare the out-
comes of pure laparoscopic (LLR) and open liver resection (OLR) in patients with hepatocellular carcinoma.
Methods We searched EMBASE, MEDLINE, Web of Science, and The Cochrane Library databases to find eligible studies. 
The most recent search was performed on December 1, 2017. Studies were regarded as suitable if they reported morbidity in 
patients undergoing LLR versus OLR. Extracted data were pooled and subsequently used in a meta-analysis with a random-
effects model. Clinical applicability of results was evaluated using predictive intervals. Review was reported following the 
PRISMA guidelines.
Results From 2085 articles, forty-three studies (N = 5100 patients) were included in the meta-analysis. Our findings showed 
that LLR had lower overall morbidity than OLR (15.59% vs. 29.88%, p < 0.001). Moreover, major morbidity was reduced 
in the LLR group (3.78% vs. 8.69%, p < 0.001). There were no differences between groups in terms of mortality (1.58% vs. 
2.96%, p = 0.05) and both 3- and 5-year overall survival (68.97% vs. 68.12%, p = 0.41) and disease-free survival (46.57% 
vs. 44.84%, p = 0.46).
Conclusions The meta-analysis showed that LLR is beneficial in terms of overall morbidity and non-procedure-specific 
complications. That being said, these results are based on non-randomized trials. For these reasons, we are calling for 
randomization in upcoming studies. Systematic review registration: PROSPERO registration number CRD42018084576.
Keywords Laparoscopic liver resection · Hepatocellular carcinoma · Meta-analysis · Systematic review
Laparoscopic liver resection is considered a feasible alter-
native to the open approach. Minimally invasive techniques 
have been widely used in the treatment of benign diseases 
such as hydatid cysts, hepatolithiasis, hemangiomas, focal 
nodular hyperplasia, and hepatic adenomas [1–3]. However, 
an increasing number of case series of malignant lesions 
scheduled for the laparoscopic approach have been published 
in the literature [4]. For instance, in other types of surgery 
laparoscopic access has been shown to be not inferior to 
an open approach in terms of oncological outcomes [5–7]. 
Most importantly, there are major well-known advantages 
related to the minimally invasive approach: less postopera-
tive pain, lower morbidity, faster recovery, and better quality 
of life [8, 9].
Despite laparoscopy gaining popularity, its clinical util-
ity and complexity in liver surgery, especially extensive 
liver resection, is still a subject of thorough analysis and 
discussion [10, 11]. It is often questioned whether reduced 
complications are enough to outweigh the benefits of open 
surgery such as the less steep learning curve and potentially 
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shorter operative time. There is, however, evidence support-
ing non-inferior outcomes, primarily overall survival (OS) 
and disease-free survival (DFS).
Moreover, operations for hepatocellular carcinoma (HCC) 
in patients with liver cirrhosis and portal hypertension are 
considered difficult and may be associated with relatively 
high morbidity [12]. It has been proved that patients with 
liver cirrhosis have worse overall outcomes and a higher 
perioperative complication rate [13, 14].
So far only few meta-analyses comparing laparoscopic 
and open liver resections for HCC have been performed, and 
have not taken into consideration variances of the techniques 
such as pure laparoscopic and hand-assisted. This may create 
potential bias when drawing conclusions [15–18]. In addi-
tion, these reviews do not cover the many large-scale studies 
published in recent years.
To our best knowledge, this is the first systematic review 
and meta-analysis to evaluate exclusively pure laparoscopic 
liver resection (LLR) compared with open liver resection 
(OLR) for HCC.
The aim of this study was to evaluate different aspects 
of LLR, including its safety (morbidity and mortality), dif-
ficulty (operative time and blood loss), and clinical utility 
(long-term survival) in comparison with OLR.
Materials and methods
Search strategy
Our literature search included EMBASE, MEDLINE, Web 
of Science, and The Cochrane Library databases. The search 
terms used were “laparoscopy,” “pure laparoscopic,” “mini-
mally invasive,” “liver resection,” “hepatectomy,” “hepato-
cellular carcinoma,” and their combinations with Boolean 
“AND” and “OR” operators. There were no date restric-
tions and only full texts in English were included. Our last 
search was performed on December 1, 2017. The full search 
strategy is available in Supplementary File 1. The system-
atic review was registered and its protocol published in the 
International Prospective Register of Systematic Reviews 
(PROSPERO) under registration number CRD42018084576.
Study selection
Results of the initial search were screened independently by 
two teams with three reviewers in each team. Studies con-
taining data comparing morbidity between patients under-
going pure laparoscopic and open liver resection for HCC 
were considered eligible for inclusion. All studies describing 
hand-assisted or hybrid resections (without subgroup data 
on pure laparoscopic resections), national registries, reviews, 
and animal studies were excluded. Both non-randomized and 
randomized studies were eligible as long as they matched 
the inclusion criteria.
Data extraction and outcome measures
Outcomes of this systematic review were overall morbid-
ity, major morbidity, specific complications (bile leak, 
abscesses, cardiopulmonary), blood loss, surgical site 
infection rate, conversion rate, operative time, reoperation 
and readmission rates, R0 resection rate, length of hospital 
stay, and 3- and 5-year OS and DFS rates. Data on type of 
study, number of patients enrolled, patients’ age and sex, 
tumor size, types of surgery, and liver function status (cir-
rhosis, Child scale) were also extracted. Major morbidity 
was extracted when stated or—if the Clavien–Dindo scale 
was used—complications rated as Clavien–Dindo grade 3 
and higher were considered major.
Statistical analysis
The analysis was performed using RevMan 5.3 (freeware 
from The Cochrane Collaboration) and R version 3.4.3 with 
meta package [19]. Statistical heterogeneity and inconsist-
ency were measured using Cochran’s Q test and I2, respec-
tively. Qualitative outcomes from individual studies were 
analyzed to assess individual and pooled risk ratios (RR) 
with pertinent 95% confidence intervals (CI) favoring pure 
laparoscopic over open liver resection for HCC and by 
means of the random-effects method. When appropriate, 
mean and standard deviation (SD) were calculated from 
medians and interquartile ranges using a method proposed 
by Hozo et al. [20]. Weighted mean differences with 95% 
CI are presented for quantitative variables using the inverse 
variance random-effects method. Statistical significance was 
observed at the two-tailed 0.05 level for hypothesis and 0.10 
level for heterogeneity testing, while unadjusted p values 
were reported accordingly. To help with clinical interpre-
tation of heterogeneity, we computed prediction intervals 
(PIs), as suggested by IntHout et al. [21], with the meta R 
package utilizing the approach of Higgins [22].
Quality assessment
The quality of non-randomized studies was evaluated with 
the Newcastle–Ottawa Scale (NOS), which consists of three 
factors: patient selection, comparability of the study groups, 
and assessment of outcomes. A score ranging from 0 to 9 is 
assigned to each study, and those that achieve a score of 6 or 
greater are considered of high quality. The Cochrane risk of 
bias tool was used to assess the quality of the included ran-
domized controlled trials. We used funnel plots and Egger’s 
test with meta-regression model to explore possible pub-
lication bias [23]. In cases of funnel plot asymmetry, the 
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trim-and-fill method was applied to estimate the cause of 
asymmetry and correct it [24].
This review was performed strictly following Preferred 
Reporting Items for Systematic Reviews (PRISMA) guide-
lines [25] and the MOOSE consensus statement [26].
Results
Study identification
The initial search yielded 3852 articles. After removing 
1767 duplicates, 2085 studies were screened by their titles 
and abstracts for further analysis. Since 1624 did not match 
the review criteria, 461 full-text articles were screened 
for eligibility and of these, 418 were later excluded. The 
PRISMA flowchart and reasons for study exclusion are 
shown in Fig. 1.
Characteristics of included studies
The characteristics of a total of 5100 patients from 43 stud-
ies included in the meta-analysis are specified in Table 1 
[27–69]. The only randomized controlled trial was con-
ducted by Jiang et al. [48].
Hospital volume
We estimated the volume of hospitals where studies were 
performed. Some institutes were noticeably very high-vol-
ume centers with almost 3000 cases in 6 years [39], while 
others performed as few as 60 procedures in 5 years [61].
Study quality
In all included studies, their quality was rated as high (≥ 6 
by assessment using the NOS scale), and the risk of bias of 
the included randomized controlled trial was low according 
to Cochrane criteria.
Type of surgery
27 studies reported data on types of resections performed, 
including number of hemihepatectomies, although the 
reporting style and detail varied between articles.
Liver function
With respect to cirrhosis in patients, 27 studies reported 
data. Of these, 11 included only patients with cirrhosis. 
In total, 1065 out of 1257 (84.73%) and 1831 out of 2150 
(85.16%) patients with cirrhosis were reported in LLR and 
OLR groups, respectively. Meanwhile, 33 studies reported 
data on patients’ Child–Pugh score, with 14 trials analyzing 
only subjects with Child–Pugh grade A.
Tumor size
35 manuscripts reported on tumor size. There is a noticeable 
trend of submitting patients with larger lesions to undergo 
OLR, leading to a potential yet incomputable bias. Pooled 
estimate analysis showed a significant trend toward smaller 
tumor sizes in LLR (mean difference − 0.26, 95% CI − 0.42 
to − 0.10, p for effect < 0.001). However, the data are highly 
heterogeneous (I2 = 79%, p < 0.001).
Fig. 1  PRISMA flowchart of 
the study 3 852 references identified for screening
2 085 studies were initially screened
1 767 duplicates removed
461 papers screened in full-text review
1 624 found irrelevant
43 studies included
for data extraction
418 citations excluded:
• conference abstract - 168
• meta-analysis - 32
• review/editorial - 33
• non-English - 3
• wrong study design - 117
• wrong intervention - 55
• wrong outcomes - 10
1494 Surgical Endoscopy (2019) 33:1491–1507
1 3
Ta
bl
e 
1 
 In
cl
ud
ed
 st
ud
ie
s s
or
te
d 
by
 y
ea
r d
es
ce
nd
in
g
St
ud
y 
[R
ef
.]
Ye
ar
C
ou
nt
ry
N
o.
 o
f p
at
ie
nt
s
C
irr
ho
si
s
C
hi
ld
–P
ug
h 
A
/B
/C
Tu
m
or
 si
ze
M
aj
or
 h
ep
at
ec
-
to
m
ie
s
H
os
pi
ta
l 
vo
lu
m
e
Re
ad
m
is
si
on
s
Pr
in
gl
e 
m
an
eu
-
ve
r u
se
N
O
S 
qu
al
ity
 
sc
or
e/
C
oc
hr
an
e 
bi
as
To
ta
l (
la
p 
vs
. 
op
en
)
%
 (l
ap
 v
s. 
op
en
)
La
p 
vs
. o
pe
n
cm
 (S
D
) (
la
p 
vs
. o
pe
n)
%
 (l
ap
 v
s. 
op
en
)
A
ll 
re
se
ct
io
ns
 
fo
r H
C
C
/y
ea
rs
%
 (l
ap
 v
s. 
op
en
)
A
m
at
o 
et
 a
l. 
[2
7]
20
17
Ita
ly
29
 (1
1 
vs
. 1
8)
N
D
10
0%
 A
N
D
0%
 v
s. 
11
.1
1%
N
D
N
D
N
D
8
C
he
n 
et
 a
l. 
[2
8]
20
17
C
hi
na
25
7 
(9
9 
vs
. 
15
8)
N
D
95
/4
 v
s. 
14
8/
10
3.
9 
(1
.5
3)
 v
s. 
4.
0 
(2
.1
5)
0%
53
4/
1.
5
N
D
N
D
7
G
ur
o 
et
 a
l. 
[2
9]
20
17
K
or
ea
10
4 
(4
6 
vs
. 5
8)
58
.7
0%
 v
s. 
65
.5
2%
41
/2
/3
 v
s. 
51
/2
/2
2.
8 
(1
.4
) v
s. 
4.
7 
(5
.2
5)
17
.3
9%
 v
s. 
31
.0
3%
N
D
N
D
N
D
8
Li
 e
t a
l. 
[3
0]
20
17
C
hi
na
22
0 
(1
33
 v
s. 
87
)
N
D
10
1/
32
 v
s. 
62
/2
5
2.
0 
(0
.5
) v
s. 
2.
3 
(0
.5
)
N
D
22
0/
5.
5
N
D
N
D
7
Ta
ra
nt
in
o 
et
 a
l. 
[3
1]
20
17
Ita
ly
64
 (1
3 
vs
. 5
1)
10
0%
 v
s. 
96
.0
8%
9 
A
 v
s. 
46
 A
N
D
0%
N
D
N
D
0%
 v
s. 
23
.5
3%
6
X
u 
et
 a
l. 
[3
2]
20
17
C
hi
na
64
 (3
2 
vs
. 3
2)
10
0%
N
D
4.
3 
(2
.2
5)
 v
s. 
6.
2 
(1
.2
3)
N
D
33
6/
2
N
D
N
D
8
X
u 
et
 a
l. 
[3
3]
20
17
C
hi
na
10
9 
(5
0 
vs
. 5
9)
86
%
 v
s. 
84
.7
5%
44
/6
 v
s. 
53
/6
3.
38
 (1
.9
9)
 v
s. 
4.
03
 (2
.6
7)
N
D
10
9/
5
0%
 v
s. 
3.
39
%
N
D
7
Yo
on
 e
t a
l. 
[3
4]
20
17
K
or
ea
66
 (3
3 
vs
. 3
3)
10
0%
10
0%
 A
3.
31
 (1
.6
5)
 v
s. 
2.
96
 (1
.5
)
N
D
15
2/
7
N
D
96
.9
7%
 v
s. 
93
.9
4%
8
A
hn
 e
t a
l. 
[3
5]
20
16
K
or
ea
12
5 
(3
2 
vs
. 9
3)
75
%
 v
s. 
66
.6
7%
28
/2
 v
s. 
83
/9
3.
1 
(1
.9
) v
s. 
3.
02
 (2
.3
)
6.
25
%
 v
s. 
15
.0
5%
13
7/
13
N
D
N
D
7
C
he
un
g 
et
 a
l. 
[3
6]
20
16
C
hi
na
44
0 
(1
10
 v
s. 
33
0)
10
0%
10
0%
 A
2.
6 
(1
.5
7)
 v
s. 
2.
85
 (1
.5
3)
10
.0
0%
 v
s. 
12
.4
2%
1,
35
8/
13
N
D
N
D
8
H
ar
ad
a 
et
 a
l. 
[3
7]
20
16
Ja
pa
n
68
 (2
0 
vs
. 4
8)
N
D
N
D
2.
4 
(1
.6
) v
s. 
2.
2 
(0
.7
)
0%
 v
s. 
6.
25
%
88
/7
.5
N
D
N
D
8
Jia
ng
 e
t a
l. 
[3
8]
20
16
C
hi
na
11
8 
(5
9 
vs
. 5
9)
N
D
10
0%
 A
3 
(0
.7
5)
 v
s. 
3 
(1
.2
5)
N
D
N
D
N
D
N
D
8
La
i e
t a
l. 
[3
9]
20
16
C
hi
na
61
 (2
8 
vs
. 3
3)
64
.2
9%
 v
s. 
66
.6
7%
N
D
3.
0 
(1
.1
) v
s. 
3.
3 
(1
.1
)
N
D
2,
91
3/
6
N
D
N
D
8
So
tir
op
ou
lo
s 
et
 a
l. 
[4
0]
20
16
G
re
ec
e
32
 (1
1 
vs
. 2
1)
N
D
N
D
N
D
0%
 v
s. 
23
.8
1%
32
/4
.5
N
D
18
.1
8%
 v
s. 
71
.4
3%
7
Sp
os
ito
 e
t a
l. 
[4
1]
20
16
Ita
ly
86
 (4
3 
vs
. 4
3)
10
0%
42
/1
 v
s. 
41
/2
N
D
2.
33
%
 v
s. 
4.
65
%
27
1/
8
N
D
N
D
8
X
ia
ng
 e
t a
l. 
[4
2]
20
16
C
hi
na
33
5 
(1
28
 v
s. 
20
7)
81
.2
5%
 v
s. 
80
.6
8%
10
8/
20
 v
s. 
18
3/
24
6.
7 
(1
.5
) v
s. 
6.
9 
(1
.5
)
N
D
39
4/
3
N
D
41
.4
1%
 v
s. 
41
.5
5%
8
Zh
an
g 
et
 a
l. 
[4
4]
20
16
C
hi
na
45
 (2
0 
vs
. 2
5)
10
0%
10
0%
 A
N
D
10
0%
N
D
0%
N
D
6
Zh
an
g 
et
 a
l. 
[4
3]
20
16
C
hi
na
77
 (3
5 
vs
. 4
2)
N
D
N
D
N
D
10
0%
N
D
N
D
N
D
6
C
ho
 e
t a
l. 
[4
5]
20
15
K
or
ea
43
 (2
4 
vs
. 1
9)
N
D
N
D
3.
7 
(1
.8
) v
s. 
4.
8 
(2
.5
)
N
D
N
D
N
D
N
D
8
1495Surgical Endoscopy (2019) 33:1491–1507 
1 3
Ta
bl
e 
1 
 (c
on
tin
ue
d)
St
ud
y 
[R
ef
.]
Ye
ar
C
ou
nt
ry
N
o.
 o
f p
at
ie
nt
s
C
irr
ho
si
s
C
hi
ld
–P
ug
h 
A
/B
/C
Tu
m
or
 si
ze
M
aj
or
 h
ep
at
ec
-
to
m
ie
s
H
os
pi
ta
l 
vo
lu
m
e
Re
ad
m
is
si
on
s
Pr
in
gl
e 
m
an
eu
-
ve
r u
se
N
O
S 
qu
al
ity
 
sc
or
e/
C
oc
hr
an
e 
bi
as
To
ta
l (
la
p 
vs
. 
op
en
)
%
 (l
ap
 v
s. 
op
en
)
La
p 
vs
. o
pe
n
cm
 (S
D
) (
la
p 
vs
. o
pe
n)
%
 (l
ap
 v
s. 
op
en
)
A
ll 
re
se
ct
io
ns
 
fo
r H
C
C
/y
ea
rs
%
 (l
ap
 v
s. 
op
en
)
H
an
 e
t a
l. 
[4
6]
20
15
K
or
ea
17
6 
(8
8 
vs
. 8
8)
62
.5
0%
 v
s. 
59
.0
9%
79
/6
/3
 v
s. 
77
/9
/2
3.
2 
(2
.0
7)
 v
s. 
3.
5 
(2
.6
7)
30
.6
8%
 v
s. 
26
.1
4%
38
9/
10
N
D
29
.5
5%
 v
s. 
14
.7
7%
8
H
ar
im
ot
o 
et
 a
l. 
[4
7]
20
15
Ja
pa
n
65
 (2
6 
vs
. 3
9)
10
0%
24
/2
 v
s. 
38
/1
2.
4 
(1
.6
) v
s. 
2.
2 
(0
.7
)
N
D
16
0/
4
N
D
N
D
6
Jia
ng
 e
t a
l. 
[4
8]
20
15
C
hi
na
10
0 
(5
0 
vs
. 5
0)
80
%
 v
s. 
72
%
N
D
3.
18
 (0
.2
9)
 v
s. 
3.
22
 (0
.3
1)
N
D
10
0/
4.
5
N
D
N
D
Lo
w
 ri
sk
 o
f b
ia
s
Le
e 
et
 a
l. 
[4
9]
20
15
C
an
ad
a
12
9 
(4
3 
vs
. 8
6)
41
.8
6%
 v
s. 
38
.3
7%
41
/1
/1
 v
s. 
81
/2
/3
N
D
N
D
43
/6
.5
2.
33
%
 v
s. 
18
.6
%
N
D
7
Lu
o 
et
 a
l. 
[5
0]
20
15
C
hi
na
10
6 
(5
3 
vs
. 5
3)
N
D
10
0%
 A
3.
0 
(0
.7
5)
 v
s. 
3.
0 
(1
.2
5)
0%
N
D
N
D
N
D
7
Ta
na
ka
 e
t a
l. 
[5
1]
20
15
Ja
pa
n
40
 (2
0 
vs
. 2
0)
10
0%
10
0%
 A
2.
33
 (0
.1
8)
 v
s. 
2.
33
 (0
.2
3)
0%
59
2/
7.
5
N
D
N
D
8
X
ia
o 
et
 a
l. 
[5
2]
20
15
C
hi
na
12
7 
(4
1 
vs
. 8
6)
80
.4
9%
 v
s. 
83
.7
2%
39
/2
 v
s. 
83
/3
4.
22
 (2
.0
5)
 v
s. 
4.
30
 (1
.4
9)
14
.6
3%
 v
s. 
12
.7
9%
12
7/
13
N
D
N
D
7
Yo
on
 e
t a
l. 
[5
3]
20
15
K
or
ea
23
2 
(5
8 
vs
. 
17
4)
10
0%
53
/5
 v
s. 
15
8/
16
2.
87
 (1
.0
5)
 v
s. 
3.
04
 (1
.1
8)
17
.2
4%
 v
s. 
18
.9
7%
1,
05
0/
4
N
D
N
D
9
A
hn
 e
t a
l. 
[5
4]
20
14
K
or
ea
10
2 
(5
1 
vs
. 5
1)
68
.6
3%
 v
s. 
66
.6
7%
10
0%
 A
2.
6 
(1
.5
) v
s. 
2.
8 
(1
.2
)
3.
92
%
 v
s. 
5.
88
%
29
2/
8
N
D
N
D
6
K
im
 e
t a
l. 
[5
5]
20
14
K
or
ea
14
6 
(7
0 
vs
. 7
6)
N
D
N
D
2.
58
 (1
.4
4)
 v
s. 
2.
45
 (1
.2
7)
5.
71
%
 v
s. 
9.
21
%
N
D
N
D
0%
6
M
em
eo
 e
t a
l. 
[5
6]
20
14
Fr
an
ce
90
 (4
5 
vs
. 4
5)
10
0%
44
/1
 v
s. 
43
/2
3.
2 
(2
.5
3)
 v
s. 
3.
7 
(3
.7
3)
N
D
33
2/
19
N
D
53
.3
3%
 v
s. 
75
.5
6%
8
Si
ni
sc
al
ch
i 
et
 a
l. 
[5
7]
20
14
Ita
ly
15
6 
(2
3 
vs
. 
13
3)
10
0%
N
D
4.
08
 (1
.5
3)
 v
s. 
3.
6 
(1
.3
3)
13
.0
4%
 v
s. 
6.
02
%
N
D
N
D
0%
6
Ya
m
as
hi
ta
 
et
 a
l. 
[5
8]
20
14
Ja
pa
n
16
2 
(6
3 
vs
. 9
9)
10
0%
59
/4
 v
s. 
96
/3
N
D
0%
65
3/
14
N
D
N
D
9
A
i e
t a
l. 
[5
9]
20
13
C
hi
na
21
2 
(7
5 
vs
. 
13
7)
80
.4
1%
 v
s. 
80
.3
4%
59
/3
8 
vs
. 
10
7/
74
7.
85
 (2
.1
5)
 v
s. 
7.
64
 (2
.3
6)
13
.4
%
 v
s. 
15
.7
3%
27
5/
4
N
D
N
D
7
K
ob
ay
as
hi
 
et
 a
l. 
[6
0]
20
13
Ja
pa
n
51
 (2
4 
vs
. 2
7)
N
D
20
/4
 v
s. 
24
/3
2.
6 
(1
.1
) v
s. 
2.
2 
(0
.5
)
0%
N
D
N
D
N
D
7
H
u 
et
 a
l. 
[6
1]
20
11
C
hi
na
60
 (3
0 
vs
. 3
0)
N
D
29
/1
 v
s. 
24
/6
6.
7 
(3
.1
) v
s. 
8.
7 
(2
.3
)
N
D
60
/5
N
D
N
D
6
K
er
 e
t a
l. 
[6
2]
20
11
Ta
iw
an
32
4 
(1
16
 v
s. 
20
8)
N
D
98
/1
7/
1 
vs
. 
19
7/
10
/1
2.
5 
(1
.2
5)
 v
s. 
5.
4 
(3
.5
)
N
D
32
4/
8
N
D
N
D
6
K
im
 e
t a
l. 
[6
3]
20
11
K
or
ea
55
 (2
6 
vs
. 2
9)
92
.3
1%
 v
s. 
86
.2
1%
N
D
3.
15
 (1
.7
5)
 v
s. 
3.
6 
(4
.5
)
19
.2
3%
 v
s. 
24
.1
4%
10
2/
4.
5
N
D
0%
7
1496 Surgical Endoscopy (2019) 33:1491–1507
1 3
Pringle maneuver
14 articles reported on use of the Pringle maneuver. 163 of 
584 (27.91%) LLR patients and 250 of 865 (28.90%) OLR 
patients underwent this technique during surgery.
Overall morbidity
All studies reported on overall morbidity. The pooled analy-
sis (Fig. 2A) indicates that LLR is connected with reduced 
overall morbidity (15.59%) compared with OLR (29.88%): 
RR = 0.53, 95% CI 0.47–0.60, p for overall effect < 0.00001, 
p for heterogeneity 0.29, I2 = 10%. The funnel plot is asym-
metric and Egger’s regression test result significant, both of 
which indicate potential publication bias. Trim-and-fill anal-
ysis was performed and 10 studies that are mirror images of 
most outlying studies were filled in, [27, 34, 43, 44, 47, 48, 
51, 62–64] as seen in Fig. 2B. Nevertheless, after this evalu-
ation, the significance of the results remained unchanged, 
with RR = 0.57, 95% CI 0.49–0.65, and PI = 0.34–0.95.
Major morbidity and mortality
Major morbidity was reported in 32 studies (n = 4080 
patients). Results in only two of them [30, 42] were signifi-
cantly different, and pooled RRs favor LLR (3.76%) over 
OLR (8.69%), with RR = 0.48, 95% CI 0.36–0.63, p for 
effect < 0.00001, p for heterogeneity 0.99, I2 = 0%, and PI 
virtually equal to CI (Fig. 3A). Thirty-two studies (n = 3657 
patients) reported data on mortality. Mortality rate in LLR 
was 1.58% versus 2.96% in OLR. Pooled analysis showed 
that mortality was also not significantly different between 
open and pure laparoscopic groups: RR = 0.64, 95% CI 
0.42–1.00, p for effect 0.05, and I2 = 0%. PI was slightly 
wider than CI, being 0.40–1.04 (Fig. 3B).
Complications
Bile leak
Bile leak rate was reported in 29 studies (n = 3831 patients). 
There were no significant differences between groups, with 
rates of 1.70% in the LLR group and 2.33% in the OLR 
group: RR = 0.77, 95% CI 0.48–1.24, p for effect 0.28, and 
I2 = 0% (Fig. 4A).
Abscesses
Fifteen trials (n = 2034 patients) reported on abscess occur-
rence. One out of 780 (0.13%) patients in the LLR group 
and 14 of 1254 (1.12%) in the OLR group had abscesses. 
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Pooled analysis showed no statistical differences between 
these groups: RR = 0.40, 95% CI 0.14–1.18 p = 0.10, I2 = 0% 
(Fig. 4B).
Pulmonary complications
Twenty-eight studies (n = 3343 patients) reported the 
occurrence of pulmonary complications: 5.01% of patients 
undergoing LLR and 10.03% in the OLR had this mor-
bidity, its rate being significantly reduced in the LLR 
group: RR = 0.58, 95% CI 0.44–0.75 (PI 0.43–0.77), p for 
effect < 0.0001, and I2 = 0% (Fig. 4C).
Blood loss
Data on blood loss were reported in 34 studies (n = 4116 
patients). The heterogeneity for this outcome was very high, 
I2 = 94%. Sensitivity analysis did not find any potential 
sources of heterogeneity. For this reason, we decided not to 
pool the results.
Operative time
Operative time was reported in 43 studies (n = 5100 
patients). We did not pool the results because of the very 
high heterogeneity (p < 0.0001, I2 = 91%). Sensitivity analy-
sis did not find specific studies that caused these results.
Length of hospital stay
Length of hospital stay was reported in 42 studies (n = 5032 
patients). However, heterogeneity was high (I2 = 85%) and 
its source was not revealed by sensitivity analysis. Thus, no 
pooling was performed.
Survival
Three-year OS was reported in 21 studies (n = 2950 
patients), while 18 (n = 2467 patients) trials reported 5-year 
OS. There were no significant variations among the analyzed 
groups: the LLR group had OS rates of 83.72% and 68.97% 
in 3 and 5 years, respectively. The OS rate in patients under-
going OLR was 80.82% in 3 years and 68.12% in 5 years. 
For 3-year OS, RR = 0.86, 95% CI 0.72–1.02, p = 0.08, 
and I2 = 6% (Fig. 5A). For 5-year OS, RR = 0.94, 95% CI 
0.82–1.09, p = 0.41, and I2 = 27% (Fig. 5B).
Nineteen studies (n = 2836 patients) reported on 3-year 
DFS. Thirteen articles (n = 1829 patients) provided informa-
tion on 5-year DFS. Pooled analysis showed no differences 
between groups for either outcome. The 3-year DFS rate was 
59.45% in the LLR group and 59.05% in the OLR group, 
while the 5-year DFS rate was 46.57% for LLR patients and 
44.84% for OLR patients. For 3-year DFS, RR = 1.02, 95% 
CI 0.90–1.15, and p = 0.81. We analyzed sources of moder-
ate heterogeneity (I2 = 47%), and in sensitivity analysis we 
found two studies that affected the results [42, 64]. After 
their removal from the meta-analysis, pooling confirmed 
previous findings, with RR = 1.01 (95% CI 0.93–1.10) and 
virtually no heterogeneity (I2 = 0%) (Fig. 6A). For 5-year 
DFS, RR = 0.97, 95% CI 0.90–1.05, p = 0.46, and I2 = 0% 
(Fig. 6B).
Discussion
Summary of findings
There is growing evidence supporting the feasibility of lapa-
roscopic liver resection for HCC, and its safety is confirmed 
in our meta-analysis. This review, including over 5000 
patients, shows that pure laparoscopy significantly reduces 
morbidity while at the same time delivering survival com-
parable with that of open surgery. Because of the very high 
heterogeneity, it is not possible to definitively assess the dif-
ferences in blood loss and operative time. Although the qual-
ity of all included studies was assessed using standardized 
tools as high, all but one are non-randomized, which may 
introduce selection bias. Moreover, there were differences in 
tumor size and in the use of the Pringle maneuver between 
LLR and OLR groups, which may cause serious bias and 
troublesome interpretation of results.
In addition, we did not include three studies because of 
the language limitations. However, based on abstract screen-
ing, number of cases in them was relatively small (less than 
50 cases). Therefore, it is very unlikely that their inclusion 
would alter the final results.
We realize that our review is not the first to be conducted 
on this topic. However, previously published meta-analyses 
on liver resections for HCC either did not take the type of 
laparoscopic technique into consideration [16–18] or per-
formed a subgroup analysis that mistakenly assigned trials 
with hybrid resections to the LRR group as in Sotiropoulos 
et al. [15]. This might have introduced a major methodologi-
cal bias to previous studies. In addition, more recent large-
scale trials are not included in previous reviews. Moreover, 
several meta-analyses, including recently published one by 
Goh et al., were limited to cirrhotic patients, which does not 
allow to draw conclusions with wide clinical applicability 
of laparoscopy [70].
These facts prompted us to revisit this topic and follow 
strict methodological and surgical criteria to obtain the best 
available evidence. Additionally, we used PIs to interpret 
whether the results would be applicable in different clinical 
settings.
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When defining the aim of our study, we strived to tackle 
the issue on different levels in terms of LLR safety (by ana-
lyzing morbidity, mortality, and specific complications), 
difficulty (operative time and blood loss), and its long-term 
results (OS and DFS).
LLR safety
Overall morbidity is crucial in our review for assessment of 
the method’s safety. Pooled analysis confirmed the benefits 
of laparoscopy with low heterogeneity and its demonstrable 
effect in different settings. It is worth noting that only one 
study, by Hu et al. [61], reported higher overall morbidity 
in LLR. Also, common general (i.e., pulmonary) complica-
tions were less likely to occur in the LLR patients, while 
procedure-associated complications (bile leak, abscesses) 
did not differ compared with OLR.
Nevertheless, results varied between studies: some 
showed an overall complication rate as high as 20.31% for 
LLR [42] while others reported no morbidity at all among 
50 patients undergoing LLR [48]. Such discrepancies can 
be explained to some extent by hospital volume or surgeon 
experience, as discussed further in the limitations of our 
review below, but it seems that the definitions and reporting 
of specific complications are not standardized, which may 
result in significant discrepancies between included studies 
and eventual bias.
Pooled analysis also showed no differences in mortal-
ity (1.58% in LLR vs. 2.96% in OLR; RR = 0.64; 95% CI 
0.42–1.00), which generally is a relatively rare complication 
in liver resections for HCC. Only one study by Xiang et al. 
[42] had a higher mortality rate in the LLR group, but it is 
important to note that this was based on one death in both 
groups: 1 out of 128 in LLR and 1 out of 208 in OLR.
Difficulty of LLR and OLR
Laparoscopy in surgery is sometimes disparaged as being 
more complex, supposedly because of the steep learning 
curve, longer operation times, and greater blood loss [71]. 
However, it has been shown that more experienced sur-
geons have, in fact, shorter median operative times as well 
as reduced blood loss and conversion rates in liver surgery 
[72]. Many parameters, such as hospital volume, are dif-
ficult to compare, which directly affects the experience and 
subsequent intraoperative results. Some studies point out 
that an increase in operative time may be a result of the 
learning curve and should improve in the future [69]. Oth-
ers, however, claim to have lowered it, as evidenced by a 
reduced conversion rate [36, 49]. This learning curve effect 
is nearly impossible to include in an analysis. These study 
limitations may be one reason why the legitimacy of LLR is 
often challenged in liver surgery. In our meta-analysis, we 
decided not to perform a pooled analysis of operative time, 
blood loss, and length of stay for reasons of significant het-
erogeneity. Even if pooling was possible, there is a potential 
bias because of highly variable operative techniques between 
centers. Most studies did not thoroughly describe the type of 
surgical devices and techniques of parenchyma transection, 
which influences the total blood loss. Another difference is 
the rate of use of the Pringle maneuver.
Usually laparoscopy is also associated with extended 
duration of surgery, but there is a possibility of patient 
selection bias reflecting surgeons’ preference to submit more 
complex cases to OLR. However, recent analyses showed 
that in liver resections a trend toward shorter operative 
time in laparoscopy may in fact be non-significant [73, 74]. 
Types of surgical instruments used in LLR may also affect 
the operative time [75].
The very high heterogeneity of these results (I2 = 94% 
for blood loss, I2 = 91% for operative time, and I2 = 85% for 
length of stay) does not allow us to draw definitive conclu-
sions, and it would seem that non-randomized trials may not 
be able to resolve this issue.
Long‑term results
The meta-analysis confirmed previous findings [17, 18] that 
LLR does not differ from OLR in terms of OS and DFS. This 
has to be juxtaposed with the clear benefits of LLR safety as 
well as its vague yet potentially greater difficulty. Our meta-
analysis of more than 5000 cases points out the weakness 
of non-randomized trials that do not allow for unequivocal 
conclusions. All studies but one, by Jiang and Cao [48], 
presented non-randomized groups. This, in our opinion, is 
a massive drawback that must be taken into account when 
discussing the data. We interpret our results as a plea for 
well-designed multicenter trials analyzing the type of sur-
gery, complexity of the procedure, surgeon’s experience, and 
hospital volume.
Due to inconsistent reporting in included manuscripts, 
we did not analyze recurrence-free survival separately from 
DFS. Although a few publications did indeed evaluate recur-
rences in LLR versus OLR, mean follow-up time varies 
significantly between studies, making it impossible to pool 
results without bias.
A very important bias results from patient allocation. 
There are indisputable differences between LLR and OLR 
patients regarding the tumor size, cirrhosis, or, intraopera-
tively, use of the Pringle maneuver. This limitation can only 
Fig. 2  A Pooled estimates of overall morbidity for pure laparoscopic 
versus open liver resection for hepatocellular carcinoma. CI con-
fidence interval, df degrees of freedom, MH Mantel–Haenszel. B 
Funnel plot for results from all studies after trim-and-fill analysis for 
overall morbidity. White dots represent filled-in studies
◂
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Fig. 3  Pooled estimates of 
major morbidity (A) and mor-
tality (B) for pure laparoscopic 
versus open liver resection for 
hepatocellular carcinoma. CI 
confidence interval, df degrees 
of freedom, MH Mantel–Haen-
szel
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0.61 [0.03, 13.87]
1.00 [0.06, 15.48]
0.14 [0.01,  2.60]
0.29 [0.02,  4.77]
0.80 [0.23,  2.77]
0.21 [0.03,  1.64]
0.54 [0.30,  0.97]
0.60 [0.13,  2.76]
0.09 [0.01,  1.58]
0.60 [0.07,  5.03]
0.25 [0.01,  4.88]
0.11 [0.01,  1.90]
Risk Ratio
0.01 0.1 1 10 100
Risk Ratio
MH, Random, 95% CI
Favours laparoscopy Favours open
Study
Total (95% CI)
Prediction interval
Heterogeneity: Tau2 = 0; Chi2 = 7.75, df = 14 (P = 0.90); I2 = 0%
Test for overall effect: Z = −1.98 (P = 0.05)
Ahn KS 2014
Ahn S 2016
Aldrighetti 2010
Amato 2017
Cheung 2016
Cho 2015
Guro 2017
Han 2015
Harada 2016
Harimoto 2015
Hu 2011
Jiang X 2016
Ker 2011
Kim HH 2011
Lai 2016
Laurent 2003
Lee JJ 2015
Lee KF 2011
Li 2017
Memeo 2014
Siniscalchi 2014
Sotiropoulos 2016
Sposito 2016
Tanaka 2015
Tranchart 2010
Truant 2011
Xiang 2016
Xiao 2015
Xu Hong−wei 2017
Xu Xiaodong 2017
Yamashita 2014
Zhang (L) 2016
Events
 0
 0
 0
 0
 0
 0
 0
19
 0
 0
 0
 0
 0
 0
 0
 0
 0
 0
 0
 1
 0
 0
 0
 0
 1
 0
 1
 0
 0
 1
 0
 0
Total
1459
  51
  32
  16
  11
 110
  24
  46
  88
  20
  26
  30
  59
 116
  26
  28
  13
  33
  43
 133
  45
  23
  11
  43
  20
  42
  36
 128
  41
  32
  50
  63
  20
Laparoscopy
Events
 0
 0
 0
 0
 6
 0
 1
22
 1
 0
 0
 0
 6
 0
 1
 2
 0
 0
 0
 6
10
 1
 0
 0
 1
 4
 1
 0
 1
 2
 0
 0
Total
2198
  51
  93
  16
  18
 330
  19
  58
  88
  48
  39
  30
  59
 202
  29
  33
  14
  33
  86
  87
  45
 133
  21
  43
  20
  42
  53
 207
  86
  32
  59
  99
  25
Open
Weight
100.0%
0.0%
0.0%
0.0%
0.0%
2.3%
0.0%
1.9%
66.0%
1.9%
0.0%
0.0%
0.0%
2.3%
0.0%
1.9%
2.2%
0.0%
0.0%
0.0%
4.4%
2.4%
2.0%
0.0%
0.0%
2.5%
2.3%
2.5%
0.0%
1.9%
3.4%
0.0%
0.0%
MH, Random, 95% CI
0.64 [0.42,  1.00]
 [0.40,  1.04]
0.23 [0.01,  4.04]
0.42 [0.02, 10.04]
0.86 [0.50,  1.48]
0.78 [0.03, 18.32]
0.13 [0.01,  2.35]
0.39 [0.02,  9.23]
0.21 [0.01,  4.08]
0.17 [0.02,  1.33]
0.27 [0.02,  4.39]
0.61 [0.03, 13.87]
1.00 [0.06, 15.47]
0.16 [0.01,  2.92]
1.62 [0.10, 25.63]
0.33 [0.01,  7.89]
0.59 [0.06,  6.32]
Risk Ratio
0.01 0.1 1 10 100
Risk Ratio
MH, Random, 95% CI
Favours laparoscopy Favours open
A
Major Morbidity
Mortality
B
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Fig. 4  Pooled estimates of bile 
leak (A), abscesses (B), and pul-
monary complications (C) for 
pure laparoscopic versus open 
liver resection for hepatocel-
lular carcinoma. CI confidence 
interval, df degrees of freedom, 
MH Mantel–Haenszel
Study
Total (95% CI)
Prediction interval
Heterogeneity: Tau2 = 0; Chi2 = 12.91, df = 21 (P = 0.91); I2 = 0%
Test for overall effect: Z = −1.08 (P = 0.28)
Ahn KS 2014
Ahn S 2016
Ai 2013
Aldrighetti 2010
Belli 2007
Chen 2017
Cheung 2016
Han 2015
Harada 2016
Harimoto 2015
Hu 2011
Jiang H 2015
Jiang X 2016
Ker 2011
Kobayashi 2013
Lai 2016
Luo 2015
Sposito 2016
Tanaka 2015
Tarantino 2017
Tranchart 2010
Xiang 2016
Xiao 2015
Xu Hong−wei 2017
Xu Xiaodong 2017
Yamashita 2014
Yoon SY 2015
Zhang (L) 2016
Zhang (R) 2016
Events
 2
 0
 0
 0
 0
 0
 0
 2
 0
 0
 3
 0
 5
 0
 0
 3
 6
 0
 0
 0
 1
 0
 1
 0
 0
 1
 1
 0
 0
Total
1467
  51
  32
  97
  16
  23
  99
 110
  88
  20
  26
  30
  50
  59
 116
  24
  28
  53
  43
  20
  13
  42
 128
  41
  32
  50
  63
  58
  20
  35
Laparoscopy
Events
 0
 2
 5
 0
 0
 0
 2
 2
 2
 1
 0
 2
 7
 4
 0
 1
 5
 0
 0
 3
 1
 3
 3
 1
 0
 2
 2
 2
 5
Total
2364
  51
  93
 178
  16
  23
 158
 330
  88
  48
  39
  30
  50
  59
 208
  27
  33
  53
  43
  20
  51
  42
 207
  86
  32
  59
  99
 174
  25
  42
Open
Weight
100.0%
2.5%
2.5%
2.8%
0.0%
0.0%
0.0%
2.5%
6.1%
2.6%
2.3%
2.7%
2.5%
19.3%
2.7%
0.0%
4.7%
18.1%
0.0%
0.0%
2.7%
3.1%
2.6%
4.6%
2.3%
0.0%
4.0%
4.0%
2.6%
2.8%
MH, Random, 95% CI
0.77 [0.48,   1.24]
 [0.46,   1.28]
5.00 [0.25, 101.63]
0.57 [0.03,  11.56]
0.17 [0.01,   2.97]
0.60 [0.03,  12.33]
1.00 [0.14,   6.94]
0.47 [0.02,   9.31]
0.49 [0.02,  11.68]
7.00 [0.38, 129.93]
0.20 [0.01,   4.06]
0.71 [0.24,   2.12]
0.20 [0.01,   3.65]
3.54 [0.39,  32.12]
1.20 [0.39,   3.69]
0.53 [0.03,   9.68]
1.00 [0.06,  15.47]
0.23 [0.01,   4.42]
0.70 [0.08,   6.52]
0.33 [0.01,   7.89]
0.79 [0.07,   8.49]
1.50 [0.14,  16.24]
0.25 [0.01,   4.88]
0.11 [0.01,   1.90]
Risk Ratio
0.01 0.1 1 10 100
Risk Ratio
MH, Random, 95% CI
Favours laparoscopy Favours open
Bile Leak
A
Study
Total (95% CI)
Prediction interval
Heterogeneity: Tau2 = 0; Chi2 = 0.32, df = 6 (P = 1.00); I2 = 0%
Test for overall effect: Z = −1.66 (P = 0.10)
Ahn KS 2014
Ahn S 2016
Ai 2013
Aldrighetti 2010
Belli 2007
Chen 2017
Cheung 2016
Han 2015
Harada 2016
Harimoto 2015
Hu 2011
Jiang X 2016
Kim HH 2011
Luo 2015
Xu Xiaodong 2017
Events
 0
 0
 1
 0
 0
 0
 0
 0
 0
 0
 0
 0
 0
 0
 0
Total
780
 51
 32
 97
 16
 23
 99
110
 88
 20
 26
 30
 59
 26
 53
 50
Laparoscopy
Events
 0
 0
 4
 0
 0
 1
 2
 0
 2
 2
 0
 1
 2
 0
 0
Total
1254
  51
  93
 178
  16
  23
 158
 330
  88
  48
  39
  30
  59
  29
  53
  59
Open
Weight
100.0%
0.0%
0.0%
24.8%
0.0%
0.0%
11.5%
12.8%
0.0%
13.1%
13.1%
0.0%
11.6%
13.1%
0.0%
0.0%
MH, Random, 95% CI
0.40 [0.14,  1.18]
 [0.10,  1.66]
0.46 [0.05,  4.05]
0.53 [0.02, 12.88]
0.60 [0.03, 12.33]
0.47 [0.02,  9.31]
0.30 [0.01,  5.93]
0.33 [0.01,  8.02]
0.22 [0.01,  4.43]
Risk Ratio
0.1 0.51 2 10
Risk Ratio
MH, Random, 95% CI
Favours laparoscopy Favours open
Abscesses
B
Study
Total (95% CI)
Prediction interval
Heterogeneity: Tau2 = 0; Chi2 = 13.53, df = 25 (P = 0.97); I2 = 0%
Test for overall effect: Z = −4.01 (P < 0.01)
Ahn KS 2014
Ahn S 2016
Ai 2013
Aldrighetti 2010
Belli 2007
Chen 2017
Cheung 2016
Han 2015
Harada 2016
Harimoto 2015
Hu 2011
Jiang H 2015
Jiang X 2016
Kim HH 2011
Kim SJ 2014
Lai 2016
Laurent 2003
Lee KF 2011
Luo 2015
Memeo 2014
Sposito 2016
Tanaka 2015
Tranchart 2010
Xiang 2016
Xiao 2015
Xu Hong−wei 2017
Xu Xiaodong 2017
Yoon YI 2017
Events
 0
 1
 5
 0
 1
 8
 5
 4
 0
 0
 0
 0
 2
 1
 2
 2
 2
 1
 2
 5
 1
 0
 1
15
 3
 2
 5
 0
Total
1358
  51
  32
  97
  16
  23
  99
 110
  88
  20
  26
  30
  50
  59
  26
  70
  28
  13
  33
  53
  45
  43
  20
  42
 128
  41
  32
  50
  33
Laparoscopy
Events
 0
 8
19
 1
 5
14
40
 6
 3
 3
 0
 2
 2
 0
 2
 5
 1
 6
 4
 8
 2
 4
 4
31
10
 9
 9
 1
Total
1985
  51
  93
 178
  16
  23
 158
 330
  88
  48
  39
  30
  50
  59
  29
  76
  33
  14
  50
  53
  45
  43
  20
  42
 207
  86
  32
  59
  33
Open
Weight
100.0%
0.0%
1.7%
8.0%
0.7%
1.7%
10.5%
8.8%
4.8%
0.8%
0.8%
0.0%
0.8%
1.9%
0.7%
1.9%
3.0%
1.4%
1.7%
2.6%
6.7%
1.3%
0.9%
1.6%
21.8%
4.7%
3.4%
6.9%
0.7%
MH, Random, 95% CI
0.58 [0.44,  0.75]
 [0.43,  0.77]
0.36 [0.05,  2.79]
0.48 [0.19,  1.25]
0.33 [0.01,  7.62]
0.20 [0.03,  1.58]
0.91 [0.40,  2.09]
0.38 [0.15,  0.93]
0.67 [0.19,  2.28]
0.33 [0.02,  6.17]
0.21 [0.01,  3.93]
0.20 [0.01,  4.06]
1.00 [0.15,  6.87]
3.33 [0.14, 78.42]
1.09 [0.16,  7.50]
0.47 [0.10,  2.24]
2.15 [0.22, 21.03]
0.25 [0.03,  2.00]
0.50 [0.10,  2.61]
0.62 [0.22,  1.76]
0.50 [0.05,  5.31]
0.11 [0.01,  1.94]
0.25 [0.03,  2.14]
0.78 [0.44,  1.39]
0.63 [0.18,  2.16]
0.22 [0.05,  0.95]
0.66 [0.23,  1.83]
0.33 [0.01,  7.90]
Risk Ratio
0.01 0.1 1 10 100
Risk Ratio
MH, Random, 95% CI
Favours laparoscopy Favours open
Pulmonary Complications
C
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Study
Total (95% CI)
Prediction interval
Heterogeneity: Tau2 < 0.01; Chi2 = 20.14, df = 19 (P = 0.39); I2 = 6%
Test for overall effect: Z = −1.73 (P = 0.08)
Ahn S 2016
Ai 2013
Cheung 2016
Guro 2017
Han 2015
Harada 2016
Kim SJ 2014
Kobayashi 2013
Lai 2016
Laurent 2003
Lee JJ 2015
Lee KF 2011
Li 2017
Sotiropoulos 2016
Sposito 2016
Tanaka 2015
Tranchart 2010
Xiang 2016
Xiao 2015
Xu Xiaodong 2017
Yoon SY 2015
Events
 2
14
11
 5
11
11
25
 0
 4
 2
 5
 6
28
 0
11
 2
11
 8
 9
11
 8
Total
1130
  32
  97
 110
  46
  88
  20
  70
  24
  28
  13
  43
  33
 133
  11
  43
  20
  42
 128
  41
  50
  58
Laparoscopy
Events
 4
22
69
11
11
23
26
 0
 5
 7
 9
10
20
 7
 9
 4
12
37
20
15
28
Total
1820
  93
 178
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  58
  88
  48
  76
  27
  33
  14
  86
  50
  87
  21
  43
  20
  42
 207
  86
  59
 174
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Weight
100.0%
1.1%
7.0%
7.5%
2.9%
4.6%
10.6%
12.8%
0.0%
1.9%
1.5%
2.7%
3.4%
10.1%
0.4%
4.7%
1.2%
5.7%
5.2%
5.7%
5.9%
5.2%
MH, Random, 95% CI
0.86 [0.72, 1.02]
 [0.66, 1.12]
1.45 [0.28, 7.56]
1.17 [0.63, 2.18]
0.48 [0.26, 0.87]
0.57 [0.21, 1.53]
1.00 [0.46, 2.19]
1.15 [0.70, 1.88]
1.04 [0.67, 1.63]
 
0.94 [0.28, 3.18]
0.31 [0.08, 1.22]
1.11 [0.40, 3.11]
0.91 [0.37, 2.26]
0.92 [0.55, 1.52]
0.12 [0.01, 1.96]
1.22 [0.56, 2.65]
0.50 [0.10, 2.43]
0.92 [0.46, 1.84]
0.35 [0.17, 0.73]
0.94 [0.47, 1.89]
0.87 [0.44, 1.71]
0.86 [0.41, 1.77]
Risk Ratio
0.01 0.1 1 10 100
Risk Ratio
MH, Random, 95% CI
Favours laparoscopy Favours open
3-Year Overall Survival
Study
Total (95% CI)
Prediction interval
Heterogeneity: Tau2 = 0.02; Chi2 = 23.26, df = 17 (P = 0.14); I2 = 27%
Test for overall effect: Z = −0.83 (P = 0.41)
Ahn KS 2014
Ahn S 2016
Cheung 2016
Cho 2015
Han 2015
Harada 2016
Hu 2011
Ker 2011
Kim SJ 2014
Lee JJ 2015
Lee KF 2011
Li 2017
Memeo 2014
Sposito 2016
Tanaka 2015
Tranchart 2010
Truant 2011
Yamashita 2014
Events
10
 3
18
 5
21
14
14
44
28
 5
 8
41
19
27
11
17
11
14
Total
999
 51
 32
110
 24
 88
 20
 30
116
 70
 43
 33
133
 45
 43
 20
 42
 36
 63
Laparoscopy
Events
  8
  9
108
  5
 24
 27
 15
 59
 32
 11
 12
 28
 25
 23
  8
 22
 29
 23
Total
1468
  51
  93
 330
  19
  88
  48
  30
 208
  76
  86
  50
  87
  45
  43
  20
  42
  53
  99
Open
Weight
100.0%
2.5%
1.2%
6.9%
1.6%
5.8%
8.5%
5.5%
10.5%
8.3%
1.9%
2.9%
8.1%
7.3%
9.1%
3.8%
6.5%
5.1%
4.7%
MH, Random, 95% CI
0.94 [0.82, 1.09]
 [0.66, 1.35]
1.25 [0.54, 2.91]
0.97 [0.28, 3.36]
0.50 [0.32, 0.78]
0.79 [0.27, 2.34]
0.88 [0.53, 1.45]
1.24 [0.85, 1.82]
0.93 [0.55, 1.58]
1.34 [0.97, 1.84]
0.95 [0.64, 1.40]
0.91 [0.34, 2.45]
1.01 [0.46, 2.20]
0.96 [0.64, 1.43]
0.76 [0.49, 1.17]
1.17 [0.82, 1.68]
1.38 [0.71, 2.68]
0.77 [0.48, 1.23]
0.56 [0.32, 0.97]
0.96 [0.53, 1.72]
Risk Ratio
0.5 1 2
Risk Ratio
MH, Random, 95% CI
Favours laparoscopy Favours open
5-Year Overall Survival
A
B
Fig. 5  Pooled estimates of 3-year (A) and 5-year (B) overall survival for pure laparoscopic vs. open liver resection for hepatocellular carcinoma. 
CI confidence interval, df degrees of freedom, MH Mantel–Haenszel
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Study
Total (95% CI)
Prediction interval
Heterogeneity: Tau2 = 0; Chi2 = 11.66, df = 16 (P = 0.77); I2 = 0%
Test for overall effect: Z = 0.22 (P = 0.83)
Ahn S 2016
Ai 2013
Cheung 2016
Guro 2017
Han 2015
Kim SJ 2014
Kobayashi 2013
Lai 2016
Laurent 2003
Lee JJ 2015
Li 2017
Sposito 2016
Tanaka 2015
Tranchart 2010
Xiao 2015
Xu Xiaodong 2017
Yoon SY 2015
Events
17
33
38
39
43
29
11
10
 5
20
46
26
12
17
12
25
26
Total
935
 32
 97
110
 46
 88
 70
 21
 28
 13
 43
133
 43
 20
 42
 41
 50
 58
Laparoscopy
Events
 41
 53
144
 51
 45
 29
 11
  8
  7
 29
 34
 24
 14
 19
 27
 24
 66
Total
1494
  93
 178
 330
  58
  88
  76
  27
  33
  14
  86
  87
  43
  20
  42
  86
  59
 174
Open
Weight
100.0%
4.6%
5.6%
8.9%
29.9%
8.3%
4.5%
1.9%
1.2%
1.0%
3.8%
5.8%
5.6%
3.4%
2.9%
2.2%
4.2%
6.1%
MH, Random, 95% CI
1.01 [0.93, 1.10]
 [0.92, 1.11]
1.21 [0.81, 1.79]
1.14 [0.80, 1.63]
0.79 [0.60, 1.05]
0.96 [0.83, 1.13]
0.96 [0.71, 1.28]
1.09 [0.73, 1.62]
1.29 [0.70, 2.37]
1.47 [0.67, 3.22]
0.77 [0.32, 1.83]
1.38 [0.89, 2.13]
0.89 [0.62, 1.26]
1.08 [0.76, 1.55]
0.86 [0.54, 1.36]
0.89 [0.55, 1.47]
0.93 [0.53, 1.65]
1.23 [0.81, 1.86]
1.18 [0.84, 1.67]
Risk Ratio
0.5 1 2
Risk Ratio
MH, Random, 95% CI
Favours laparoscopy Favours open
Study
Total (95% CI)
Prediction interval
Heterogeneity: Tau2 = 0; Chi2 = 10.70, df = 12 (P = 0.56); I2 = 0%
Test for overall effect: Z = −0.85 (P = 0.39)
Ahn KS 2014
Ahn S 2016
Cheung 2016
Cho 2015
Han 2015
Lee JJ 2015
Lee KF 2011
Li 2017
Memeo 2014
Sposito 2016
Tranchart 2010
Truant 2011
Yamashita 2014
Events
17
19
53
14
49
20
18
50
37
32
23
23
42
Total
743
 51
 32
110
 24
 88
 43
 33
133
 45
 43
 42
 36
 63
Laparoscopy
Events
 23
 49
172
  9
 52
 36
 22
 42
 35
 38
 27
 35
 59
Total
1086
  51
  93
 330
  19
  88
  86
  50
  87
  45
  43
  42
  53
  99
Open
Weight
100.0%
2.6%
5.4%
13.3%
1.9%
9.9%
3.9%
3.3%
6.7%
15.0%
15.1%
5.1%
6.6%
11.3%
MH, Random, 95% CI
0.97 [0.89, 1.05]
 [0.88, 1.06]
0.74 [0.45, 1.21]
1.13 [0.80, 1.59]
0.92 [0.74, 1.15]
1.23 [0.69, 2.20]
0.94 [0.73, 1.22]
1.11 [0.74, 1.67]
1.24 [0.80, 1.93]
0.78 [0.57, 1.06]
1.06 [0.86, 1.30]
0.84 [0.69, 1.03]
0.85 [0.60, 1.22]
0.97 [0.71, 1.32]
1.12 [0.88, 1.42]
Risk Ratio
0.5 1 2
Risk Ratio
MH, Random, 95% CI
Favours laparoscopy Favours open
3-Year Disease-Free Survival
A
5-Year Disease-Free Survival
B
Fig. 6  Pooled estimates of 3-year (A) and 5-year (B) disease-free survival for pure laparoscopic versus open liver resection for hepatocellular 
carcinoma. Forest plot presents studies after sensitivity analysis. CI confidence interval, df degrees of freedom, MH Mantel–Haenszel
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be overcome by randomized controlled trials. Moreover, 
center volumes highly differ, as does surgeons’ experience. 
The latter was not reported in our included studies despite 
it being an extremely important factor in complex liver sur-
geries. In addition, use of the Pringle maneuver reported in 
the studies varies and resulted in very high heterogeneity. 
Finally, we did not analyze the potential impact of surgical 
technique and its differences between studies. Neither were 
perioperative care protocols considered, despite their appli-
cation having been shown to be beneficial in many surgical 
disciplines [76, 77].
Conclusions
This systematic review with a meta-analysis, thus far the 
most comprehensive analysis comparing pure LLR with 
OLR for HCC, reveals major flaws in the available litera-
ture. The results indicate that LLR is safe in different clini-
cal settings as it may be associated with reduced overall 
morbidity and non-procedure-specific complications, and 
no negative influence on mortality as well as OS and DFS. 
However, these results are based on non-randomized trials 
comparing heterogeneous groups of patients, thus introduc-
ing confounding variables from the outset.
In our opinion, therefore, there is no need for further 
non-randomized trials proving the feasibility and safety of 
LLR. This is a plea for large, multicenter, well-designed ran-
domized controlled trials that can overcome the weaknesses 
of the available evidence.
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